Prognostic biomarkers of IFNb therapy in multiple sclerosis patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 7, Pages 894-904
Publisher
SAGE Publications
Online
2014-11-13
DOI
10.1177/1352458514555786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Efficacy and safety of subcutaneous interferon beta-1a in relapsing–remitting multiple sclerosis: Further outcomes from the IMPROVE study
- (2011) Nicola De Stefano et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
- (2011) Gavin Giovannoni et al. LANCET NEUROLOGY
- Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis
- (2011) Richard A. Rudick et al. PLoS One
- Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
- (2010) Chris J Hedegaard et al. Multiple Sclerosis Journal
- Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing—remitting multiple sclerosis
- (2010) Nicola De Stefano et al. Multiple Sclerosis Journal
- Correlations between RNA and protein expression profiles in 23 human cell lines
- (2009) Marcus Gry et al. BMC GENOMICS
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Absence of MxA induction by interferon in patients with MS reflects complete loss of bioactivity
- (2009) D. Hesse et al. NEUROLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes
- (2008) Yanfang Guo et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis
- (2008) Kaushal S. Gandhi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started